KITLG and neoplasm: For example, Ebos et al (2007) showed that administration of a VEGFR tyrosine kinase inhibitor to non-tumour-bearing mice led to an increase in levels of circulating cytokines such as granulocyte colony-stimulating factor, SDF-1α, stem cell factor and osteopontin.